<html>
<head>PUBMED IDs for PARK9</head>
<body bgcolor='#C5F0F2'><h1>PARK9</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14598065/'>DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism.</a> November 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16964263/'>Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.</a> September 12  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17713121/'>[Pathology of familial Parkinson's disease].</a> August 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18442138/'>Parkinson's disease in Arabs: a systematic review.</a> April 30  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19705361/'>ATP13A2 variants in early-onset Parkinson's disease patients and controls.</a> January 13  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20310007/'>ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.</a> September 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20310006/'>MTR polymorphic variant A2756G and retinoblastoma risk in Brazilian children.</a> May 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20310005/'>Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1.</a> May 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20683840/'>Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations.</a> December 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20694531/'>Rare causes of dystonia parkinsonism.</a> January 12  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20694526/'>Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study.</a> February 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20817231/'>Emerging parkinsonian phenotypes.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20817226/'>MTHFR polymorphisms in relation to ovarian cancer risk.</a> October 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20853184/'>Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability.</a> May 7  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20945983/'>Autosomal recessive mutations in the development of Parkinson's disease.</a> February 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21542062/'>Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.</a> December 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21665991/'>Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death.</a> January 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22022275/'>A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier.</a> February 11  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22022274/'>Transcriptional robustness complements nonsense-mediated decay in humans.</a> February 11  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22186024/'>PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity.</a> June 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22166450/'>Autosomal recessive parkinsonism.</a> August 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22285144/'>ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22288903/'>Hypoxia regulation of ATP13A2 (PARK9) gene transcription.</a> August 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22442086/'>Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity.</a> May 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22457822/'>The role of the Parkinson's disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeast.</a> August 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22490479/'>Lack of association between three single nucleotide polymorphisms in the PARK9, PARK15, and BST1 genes and Parkinson's disease in the northern Han Chinese population.</a> August 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22645275/'>Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.</a> December 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22647602/'>Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.</a> August 29  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22768177/'>Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22768174/'>Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22847264/'>Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants.</a> April 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22885599/'>Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove.</a> January 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23393156/'>Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.</a> November 2  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23499937/'>ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neurons.</a> June 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23522931/'>The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson's disease.</a> January 31  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23522888/'>The Lombardy Rare Donor Programme.</a> November 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23522856/'>PLAC4 is upregulated in severe early onset preeclampsia and upregulated with syncytialisation but not hypoxia.</a> November 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24130856/'>CATP-6, a C. elegans ortholog of ATP13A2 PARK9, positively regulates GEM-1, an SLC16A transporter.</a> June 25  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24603074/'>Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.</a> January 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24729340/'>Low prevalence of most frequent pathogenic variants of six PARK genes in sporadic Parkinson's disease.</a> April 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24742361/'>Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.</a> February 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24742351/'>Probabilistic drug connectivity mapping.</a> August 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24742347/'>HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells.</a> March 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24742333/'>E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24742330/'>Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25197640/'>Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.</a> June 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25461191/'>α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).</a> August 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25548536/'>ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells.</a> December 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25900096/'>The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.</a> April 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27073711/'>Protection against Mitochondrial and Metal Toxicity Depends on Functional Lipid Binding Sites in ATP13A2.</a> April 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27485256/'>Simple and rapid characterization of novel large germline deletions in SDHB, SDHC and SDHD-related paraganglioma.</a> August 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28137957/'>Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).</a> May 13  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28302480/'>Comprehensive investigation of aberrant microRNAs expression in cells culture model of MnCl2-induced neurodegenerative disease.</a> March 18  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28302418/'>LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.</a> March 18  2017<br></body></html>
